Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Searle pays milestone to Epimmune for anticancer candidate

Aug. 31, 1999

LB-42908 inhibits protein farnesyltransferase in vitro, in vivo

Aug. 30, 1999

Preclinical studies of abetafen show potential for treatment of prostate disease

Aug. 30, 1999

Cytotoxic macrolide compounds HA-1 and TH-2 obtained from marine sources

Aug. 30, 1999

NaPro BioTherapeutics focuses on new anticancer programs

Aug. 30, 1999

NuOncology Labs awarded second U.S. patent

Aug. 30, 1999

Evacet/Taxol combination enters advanced breast cancer trials

Aug. 30, 1999

Cell Pathways seeks approval of Aptosyn in the U.S.

Aug. 27, 1999

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Aug. 27, 1999

ACS news flash: Agouron investigates CDK inhibitors as anticancer agents

Aug. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...